The deal also calls for the construction of a new facility at focused on engineering called the McLaren GSK Centre for Applied Performance. The facility will be built at McLaren’s headquarters outside ...

GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...

is using emerging radio frequency identification (RFID) technology as part of a pilot program to crack down on drug counterfeiting and to protect consumers. GSK said Wednesday that bottles of its HIV ...

GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas. Protas will provide a variety of scientifically led and operational ...

GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital ...

-GSK on Tuesday agreed to buy U.S. biotech Affinivax for up to $3.3 billion, its second major deal in two months, giving the ...

Pharma giant GSK and venture capital-backed Elegen are partnering to leverage the DNA manufacturer's proprietary technology to help develop new vaccines and medicines. Under the deal, Elegen could net ...

Pharmaceutical company GSK has paid $70 million to partner with precision medicine company Tempus. Through the partnership, GSK will have access to Tempus’ artificial intelligence platform and ...

GlaxoSmithKline has signed a multiyear partnership agreement with artificial intelligence-powered pathology company PathAI, according to an April 5 news release. The partnership will focus on ...

NICE now recommends Nucala for both severe asthma and COPD, expanding the drug’s clinical uptake across the UK’s public ...